WHAT’S BEING CLAIMED:
- In June 2018, Roxli Doss, 11, was diagnosed with diffuse intrinsic pontine glioma (DIPG) — a type of brain tumor that has no cure.
- Roxli’s family was given the news that the tumor was inoperable that’s why they resorted to an 11-week course of radiation.
- After six months, the 11-year-old tumor’s vanished without a trace, according to her latest MRI scan, which baffled the medical community.
Roxli Doss was diagnosed with diffuse intrinsic pontine glioma (DIPG) in June and was told that the brain tumor is inoperable and has no cure. Her family was devastated by the news and proceeded to an 11-week course of radiation.
The young girl’s tumor was diagnosed by specialists at multiple institutions, including Johns Hopkins.
Half a year later, Roxli’s doctors were baffled to discover that the tumor has disappeared. The young girl’s MRIs are clear of any trace of the tumor.
“It is very rare, but when we see it, it is a devastating disease,” Dr. Virginia Harrod of Dell Children’s Medical Center said. “You have decreased ability to swallow, sometimes vision loss, decreased ability to talk, eventually difficulty with breathing.”
Despite being told that DIPG has no cure, Roxli’s family decided to proceed with an 11-week course of radiation. After her diagnosis, they were assisted financially by friends and family as well as other people who donated to a benefit the family held a couple of months. The family has also launched a GoFundMe campaign to offset some of the high costs.
Roxli underwent radiation therapy because it has been shown to delay the growth of cancers by killing off cancer cells over time. However, numerous sessions are needed to make progress against the cancer. Radiation alone cannot be considered a cure for the disease.
It’s unclear if this is a rare exception to that rule or if something else was at play that has eluded medical professionals, CBS News reports.
While the brain tumor appears to have completely vanished, Roxli’s doctors and her family are taking the situation carefully. The 11-year-old will still undergo additional tests and treatments in order to increase the odds against the cancer’s possible return.